MIAMI LAKES, Fla., Nov. 26, 2014 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) Chief Executive Officer, Mohan Gopalkrishnan, will present a business overview and update at the LD Micro Investor Conference Thursday, December 4, 2014 at 7:30 am PST (10:30 am EST).
A live webcast and replay of the presentation will be available on the investor relations section of the Company's corporate website, www.erbadiagnostics.com. The replay of the webcast will be archived for 90 days.
About LD Micro
LD Micro is an investment newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published reports on select companies throughout the year. The firm also hosts the LD Micro Invitational. It is a non-registered investment advisor. For more information, please contact 408-457-1042 or visit www.ldmicro.com.
About ERBA Diagnostics, Inc.
ERBA Diagnostics, Inc. (NYSE MKT:ERB) is a fully integrated in vitro diagnostics company, offering a comprehensive suite of clinical testing products throughout the U.S. and emerging markets. The Company serves as a one-stop shop for the testing needs of the growing number of smaller hospitals, reference labs, and physician clinics. ERBA Diagnostic's line of proprietary and automated instruments, test kits, and reagents provide customers with autoimmune, infectious diseases, clinical chemistry, hematology, and diabetes testing. www.erbadiagnostics.com
CONTACT: Investors & Media Tom Baker Stonegate, Inc. Tel: 617.532.0624 firstname.lastname@example.org
Source:ERBA Diagnostics Inc